Document Detail


Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice.
MedLine Citation:
PMID:  22058427     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Lipin-1 is the major phosphatidate phosphatase (PAP) in the heart and a transcriptional coactivator that regulates fatty acid (FA) oxidation in the liver. As the control of FA metabolism is essential for maintaining cardiac function, we investigated whether lipin-1 deficiency affects cardiac metabolism and performance. Cardiac PAP activity in lipin-1 deficient [fatty liver dystrophy (fld)] mice was decreased by >80% compared with controls. Surprisingly, oleate oxidation and incorporation in triacylglycerol (TG), as well as glucose oxidation, were not significantly different in perfused working fld hearts. Despite this, [³H]oleate accumulation in phosphatidate and phosphatidylinositol was increased in fld hearts, reflecting the decreased PAP activity. Phosphatidate accumulation was linked to increased cardiac mammalian target of rapamycin complex 1 (mTORC1) signaling and endoplasmic reticulum (ER) stress. Transthoracic echocardiography showed decreased cardiac function in fld mice; however, cardiac dysfunction was not observed in ex vivo perfused working fld hearts. This showed that changes in systemic factors due to the global absence of lipin-1 could contribute to the decreased cardiac function in vivo. Collectively, this study shows that fld hearts exhibit unchanged oleate esterification, as well as oleate and glucose oxidation, despite the absence of lipin-1. However, lipin-1 deficiency increases the accumulation of newly synthesized phosphatidate and induces aberrant cell signaling.
Authors:
Bernard P C Kok; Petra C Kienesberger; Jason R B Dyck; David N Brindley
Related Documents :
19371187 - Noninvasive assessment of myocardial ischemia in the future: fusion of anatomical and f...
10895407 - Evaluation of myocardial viability in asymptomatic patients early after infarction with...
10350197 - Cobalt-55 positron emission tomography in recurrent ischaemic stroke.
15824927 - Comparison of 99mtc-sestamibi/18fdg disa spect with pet for the detection of viability ...
15519017 - A hard look at angiotensin receptor blockers in heart failure.
23111407 - Subclinical coronary atherosclerosis in young adults: prevalence, characteristics, pred...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-11-05
Journal Detail:
Title:  Journal of lipid research     Volume:  53     ISSN:  0022-2275     ISO Abbreviation:  J. Lipid Res.     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-16     Completed Date:  2012-04-09     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  0376606     Medline TA:  J Lipid Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  105-18     Citation Subset:  IM    
Affiliation:
Signal Transduction Research Group, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Fatty Liver / physiopathology
Glucose / metabolism*
Heart / physiology*
Male
Mice
Myocardium / metabolism
Nuclear Proteins / deficiency*
Oleic Acid / metabolism*
Phosphatidate Phosphatase / deficiency*
Triglycerides / biosynthesis
Grant Support
ID/Acronym/Agency:
//Canadian Institutes of Health Research
Chemical
Reg. No./Substance:
0/Nuclear Proteins; 0/Triglycerides; 112-80-1/Oleic Acid; 50-99-7/Glucose; EC 3.1.3.4/Lpin1 protein, mouse; EC 3.1.3.4/Phosphatidate Phosphatase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the ...
Next Document:  CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women.